JPMorgan analyst Steven Alexopoulos raised the firm’s price target on Synovus to $37 from $35 and keeps an Overweight rating on the shares ahead of the Q2 results. With the peak increase in deposit costs likely in Q2, “another buy signal appears likely” for small cap banks, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on SNV:
- Synovus price target lowered to $34 from $35 at Truist
- 5 Best Bank Stocks to Invest in Now, According to Analysts – May 2023
- KRE: Be Greedy When Others are Fearful with This Regional Banking ETF
- Regional Bank Stocks Continue Crypto-like Volatility
Questions or Comments about the article? Write to editor@tipranks.com